COMPARISON OF SPIRONOLACTONE TABLET DOSAGE FORMS IN HEALTHY HUMANS

被引：10
|
作者：
HOFMANN, LM
DUTT, JE
DEYSACH, LG
LONCIN, H
TAO, L
机构：
[1] GD SEARLE & CO, DEPT CORP INFORMATION, MATH STATISTICAL SERV, CHICAGO, IL 60680 USA
[2] GD SEARLE & CO, DEPT CLIN RES, CHICAGO, IL 60680 USA
[3] GD SEARLE & CO, DEPT BIOL RES, CHICAGO, IL 60680 USA
来源：
JOURNAL OF PHARMACEUTICAL SCIENCES | 1974年 / 63卷 / 08期
关键词：
D O I：
10.1002/jps.2600630817
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：1248 / 1253
页数：6
相关论文
共 50 条
  • [1] PHARMACOKINETIC COMPARISON OF TABLET AND SUSPENSION DOSAGE FORMS OF CARBAMAZEPINE
    WADA, JA
    TROUPIN, AS
    FRIEL, P
    REMICK, R
    LEAL, K
    PEARMAIN, J
    EPILEPSIA, 1978, 19 (03) : 251 - 255
  • [2] EVALUATION OF DOSAGE FORMS .3. STUDIES ON COMMERCIAL ACETAMINOPHEN TABLET DOSAGE FORMS
    RAZDAN, B
    VERMA, PK
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 79 (2-3) : 83 - 88
  • [3] HPLC determination of Escitalopram in tablet dosage forms
    Balkanski, Stefan
    PHARMACIA, 2022, 69 (01) : 21 - 24
  • [4] Bioequivalence evaluation of new microparticulate capsule and marketed tablet dosage forms of lornoxicam in healthy volunteers
    Shah, Pervaiz Akhtar
    Bashir, Sajid
    Ahsan, Muhammad
    Abbas, Nasir
    Malik, Muhammad Zubair
    Nazar, Hafiz Muhammad Irfan
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 15 (04) : 877 - 883
  • [5] A Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers
    Lin Pan
    Paula Belloni
    Han Ting Ding
    Jianshuang Wang
    Christopher M. Rubino
    Wendy S. Putnam
    Advances in Therapy, 2017, 34 : 2071 - 2082
  • [6] A Pharmacokinetic Bioequivalence Study Comparing Pirfenidone Tablet and Capsule Dosage Forms in Healthy Adult Volunteers
    Pan, Lin
    Belloni, Paula
    Ding, Han Ting
    Wang, Jianshuang
    Rubino, Christopher M.
    Putnam, Wendy S.
    ADVANCES IN THERAPY, 2017, 34 (09) : 2071 - 2082
  • [7] Evaluation of dosage forms. IV. Studies on commercial phenylbutazone tablet dosage forms
    Razdan, B
    Paradkar, AR
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1998, 24 (07) : 599 - 604
  • [8] Evaluation of dosage forms. VI. Studies of commercial oxyphenbutazone tablet dosage forms
    Razdan, B
    Nagaraj, NV
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (09) : 1051 - 1056
  • [9] INVITRO AND INVIVO AVAILABILITY OF SPIRONOLACTONE FROM ORAL DOSAGE FORMS
    CHAO, AY
    SANVORDEKER, DR
    ZAGARELLA, J
    MATTES, K
    NICHOLOVA, B
    KARIM, A
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1976, 65 (11) : 1630 - 1634
  • [10] COMPARATIVE BIOAVAILABILITY OF 2 FORMS OF SPIRONOLACTONE - RATIONALIZATION APPLIED TO DOSAGE
    DATHIS, P
    RICHARD, MO
    DELAUTURE, D
    REY, E
    DYVOIRE, MB
    CLEMENT, E
    OLIVE, G
    THERAPIE, 1981, 36 (04): : 443 - 449
12345